WIPO logo
Mobile | Deutsch | Español | Français | 日本語 | 한국어 | Português | Русский | 中文 | العربية |
PATENTSCOPE

Search International and National Patent Collections
World Intellectual Property Organization
Search
 
Browse
 
Translate
 
Options
 
News
 
Login
 
Help
 
Machine translation
1. (WO2009129508) SOLUBLE EPOXIDE HYDROLASE INHIBITORS
Latest bibliographic data on file with the International Bureau   

Pub. No.:    WO/2009/129508    International Application No.:    PCT/US2009/041038
Publication Date: 22.10.2009 International Filing Date: 17.04.2009
IPC:
C07D 401/06 (2006.01), C07D 405/14 (2006.01), C07D 489/04 (2006.01), A61K 31/4545 (2006.01), A61K 31/5377 (2006.01), A61K 31/5383 (2006.01), A61P 9/00 (2006.01)
Applicants: ARETE THERAPEUTICS, INC. [US/US]; 7000 Shoreline Ct. Suite 201 San Francisco, CA 94080 (US) (For All Designated States Except US).
AAVULA, Bhasker, R. [US/US]; (US) (For US Only).
ANANDAN, Sampath-Kumar [US/US]; (US) (For US Only).
GLESS, Richard, D. [US/US]; (US) (For US Only)
Inventors: AAVULA, Bhasker, R.; (US).
ANANDAN, Sampath-Kumar; (US).
GLESS, Richard, D.; (US)
Priority Data:
61/046,316 18.04.2008 US
Title (EN) SOLUBLE EPOXIDE HYDROLASE INHIBITORS
(FR) INHIBITEURS DE L’ÉPOXYDE HYDROLASE SOLUBLE
Abstract: front page image
(EN)Disclosed are amide, thioamide, urea and thiourea compounds and compositions that inhibit soluble epoxide hydrolase (sEH), methods for preparing the compounds and compositions, and methods for treating patients with such compounds and compositions. The compounds, compositions, and methods are useful for treating a variety of sEH mediated diseases, including hypertensive, cardiovascular, inflammatory, and diabetic-related diseases.
(FR)L’invention concerne des composés amide, thioamide, urée et thiourée et de compositions qui inhibent l’époxyde hydrolase soluble (sEH), des procédés pour la préparation des composés et compositions, et des procédés pour le traitement de patients avec de tels composés et compositions. Les composés, compositions et procédés sont utiles pour traiter toute une série de maladies véhiculées par sEH, notamment les maladies hypertensives, cardiovasculaires, inflammatoires et associées au diabète.
Designated States: AE, AG, AL, AM, AO, AT, AU, AZ, BA, BB, BG, BH, BR, BW, BY, BZ, CA, CH, CN, CO, CR, CU, CZ, DE, DK, DM, DO, DZ, EC, EE, EG, ES, FI, GB, GD, GE, GH, GM, GT, HN, HR, HU, ID, IL, IN, IS, JP, KE, KG, KM, KN, KP, KR, KZ, LA, LC, LK, LR, LS, LT, LU, LY, MA, MD, ME, MG, MK, MN, MW, MX, MY, MZ, NA, NG, NI, NO, NZ, OM, PG, PH, PL, PT, RO, RS, RU, SC, SD, SE, SG, SK, SL, SM, ST, SV, SY, TJ, TM, TN, TR, TT, TZ, UA, UG, US, UZ, VC, VN, ZA, ZM, ZW.
African Regional Intellectual Property Organization (BW, GH, GM, KE, LS, MW, MZ, NA, SD, SL, SZ, TZ, UG, ZM, ZW)
Eurasian Patent Organization (AM, AZ, BY, KG, KZ, MD, RU, TJ, TM)
European Patent Office (AT, BE, BG, CH, CY, CZ, DE, DK, EE, ES, FI, FR, GB, GR, HR, HU, IE, IS, IT, LT, LU, LV, MC, MK, MT, NL, NO, PL, PT, RO, SE, SI, SK, TR)
African Intellectual Property Organization (BF, BJ, CF, CG, CI, CM, GA, GN, GQ, GW, ML, MR, NE, SN, TD, TG).
Publication Language: English (EN)
Filing Language: English (EN)